Fig. 2From: Mechanism of the blood pressure-lowering effect of sodium-glucose cotransporter 2 inhibitors in obese patients with type 2 diabetesChanges in 24-h urinary collection data up to 6 months after administration of sodium-glucose cotransporter 2 inhibitors (n = 20). W, weeks; M, months; *, P < 0.05; **, P < 0.01Back to article page